Sanofi : Sanofi Board of Directors Provides Update

Sanofi Board of Directors Provides Update

Paris, France - September 6, 2016 - Sanofi's Board of Directors was informed by Bonnie L. Bassler that she wished to resign as a Director of Sanofi due to a potential conflict of interest related to her impending membership on another board. Accordingly, her resignation was accepted, effective September 6th.


About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).



Media Relations
Laurence Bollack
Tel. : +33 (0)1 53 77 46 46
Investor Relations
George Grofik
Tel.: +33 (0)1 53 77 45 45



This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies